Scottsdale, Arizona Clinical Trials

A listing of Scottsdale, Arizona clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 68 clinical trials
Test_Trial 01  

Study 01

Test Site 3
 (8.8 away)
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
Formal Testing 01  

Test Comment

Test Site 3
 (8.8 away)
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
Trial 001.  

qa123

Test Site 3
 (8.8 away)
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
qa123

sdf

Test Site 3
 (8.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Smoke Testing v6.14.1  

Testing

Test Site 3
 (8.8 away)
  • 0 views
  • 14 Jun, 2024
  • +5 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

mini-mental state examination
alzheimer's disease
positron emission tomography
florbetapir
flortaucipir
Banner Alzheimer's Institute
 (7.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +85 other locations
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B With or Without Inhibitory Antibodies to Factor VIII or IX

Primary Objective: To characterize the long-term safety and tolerability of fitusiran Secondary Objectives: To characterize the long-term efficacy of fitusiran as assessed by the frequency of: Bleeding episodes Spontaneous bleeding episodes Target joint bleeding episodes To characterize the effects of fitusiran on health-related quality of life (HRQOL) measures in participants …

antihemophilic factor
haemophilia a
hemarthrosis
fitusiran
hemophilia
Investigational Site Number 8400009
 (6.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +43 other locations
manual trial test  

manual trial test overview

Test Site 3
 (8.8 away)
  • 0 views
  • 19 Feb, 2024
  • +10 other locations
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

progranulin
dementia
aphasia
pick's disease
Dignity Health
 (9.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +46 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

lasmiditan
preventive medication
headache
migraine
ly573144
Barrow Neurological Institute at Phoenix Children's Hospital
 (6.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +162 other locations